Analysts who follow Solid Biosciences Inc (SLDB) on average expect it to climb 733.33% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns Solid Biosciences Inc an Analyst Ranking of 27, which means it ranks higher than 27 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating SLDB a Buy today. Find out what this means to you and get the rest of the rankings on SLDB!